Insider · CIK 0001705278
Catherine C. Turkel
Files at LEXX (Lexaria Bioscience Corp.). First filing Aug 13, 2024, latest Aug 13, 2024.
In brief
Catherine C. Turkel files SEC Form 4 as director at LEXX (Lexaria Bioscience Corp.). Since Aug 13, 2024, Catherine C. Turkel has reported 1 open-market buy worth $5,008 and 0 open-market sells worth $0, the latest filed on Aug 13, 2024.
A track record needs three past buys with six months of prices behind them; Catherine C. Turkel has 0, so none is measured yet.
The newest scored trade: bought $5,008 of LEXX on Aug 12, 2024, filed Aug 13, 2024, scored 33 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LEXX: Lexaria Bioscience Corp.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 33Weak | LEXXbuy Lexaria Bioscience Corp. | $5,008 1,600 shares | +107% | +279% from low-48% from high |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 12, 2024 | LEXX Lexaria Bioscience Corp. | POpen-market purchase common shares | +1,600 | $3.13 | $5,008 | 3,100 | Aug 13, 2024 |
| Jul 26, 2024 | LEXX Lexaria Bioscience Corp. | AGrant or award Stock Optionsderivative | +12,000 | $0.00 | $0 | 27,000 | Jul 30, 2024 |
| Apr 26, 2024 | LEXX Lexaria Bioscience Corp. | AGrant or award Stock Optionsderivative | +5,000 | $0.00 | $0 | 15,000 | May 10, 2024 |
Questions about Catherine C. Turkel
Answered from the filings on this page, as of the latest one.
Is Catherine C. Turkel buying or selling?
Not in the last 12 months. Catherine C. Turkel's latest open-market trade on SEC Form 4 was bought $5,008 of LEXX on Aug 12, 2024.
How did Catherine C. Turkel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Catherine C. Turkel has 0.
Where does Catherine C. Turkel file Form 4?
Catherine C. Turkel has filed Form 4 at LEXX (Lexaria Bioscience Corp.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.